Cytek Biosciences Future Growth
Future criteria checks 4/6
Cytek Biosciences is forecast to grow earnings and revenue by 114.3% and 13.9% per annum respectively. EPS is expected to grow by 112.9% per annum. Return on equity is forecast to be 9.5% in 3 years.
Key information
114.3%
Earnings growth rate
112.9%
EPS growth rate
| Life Sciences earnings growth | 17.4% |
| Revenue growth rate | 13.9% |
| Future return on equity | 9.5% |
| Analyst coverage | Low |
| Last updated | 07 Aug 2024 |
Recent future growth updates
Recent updates
An Intrinsic Calculation For Cytek Biosciences, Inc. (NASDAQ:CTKB) Suggests It's 49% Undervalued
Aug 09
Is Cytek Biosciences (NASDAQ:CTKB) Using Debt Sensibly?
Jul 12Potential Upside For Cytek Biosciences, Inc. (NASDAQ:CTKB) Not Without Risk
Jun 04Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader
Mar 20Cytek Biosciences' (NASDAQ:CTKB) Solid Profits Have Weak Fundamentals
Mar 08Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization Investments
Jul 27Checking In On Cytek Biosciences
Mar 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 276 | 14 | N/A | N/A | 4 |
| 12/31/2025 | 241 | -2 | N/A | N/A | 5 |
| 12/31/2024 | 206 | -10 | N/A | N/A | 5 |
| 6/30/2024 | 198 | -18 | 11 | 15 | N/A |
| 3/31/2024 | 201 | -12 | 1 | 6 | N/A |
| 12/31/2023 | 193 | -12 | 0 | 5 | N/A |
| 9/30/2023 | 183 | -14 | -8 | 2 | N/A |
| 6/30/2023 | 176 | -6 | -11 | -1 | N/A |
| 3/31/2023 | 166 | -2 | -17 | -8 | N/A |
| 12/31/2022 | 164 | 2 | -22 | -12 | N/A |
| 9/30/2022 | 155 | -1 | -18 | -13 | N/A |
| 6/30/2022 | 148 | -3 | -9 | -4 | N/A |
| 3/31/2022 | 139 | -2 | -3 | 1 | N/A |
| 12/31/2021 | 128 | 0 | 0 | 5 | N/A |
| 9/30/2021 | 120 | 1 | 8 | 11 | N/A |
| 6/30/2021 | 110 | 2 | 9 | 12 | N/A |
| 3/31/2021 | 99 | 4 | 14 | 16 | N/A |
| 12/31/2020 | 93 | 3 | 14 | 15 | N/A |
| 12/31/2019 | 58 | -17 | -15 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CTKB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: CTKB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CTKB is expected to become profitable in the next 3 years.
Revenue vs Market: CTKB's revenue (13.9% per year) is forecast to grow faster than the US market (8.5% per year).
High Growth Revenue: CTKB's revenue (13.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CTKB's Return on Equity is forecast to be low in 3 years time (9.5%).